Author
Company Overview Gartner, Inc. (NYSE: IT) is a leading global research and advisory company operating through three segments: Research, Conferences, and Consulting…
By Franklin Jay
Read moreIntroduction Leidos Holdings (NYSE: LDOS) is a leading U.S. defense and IT contractor known for providing technology solutions to government and commercial clients. The company…
By Franklin Jay
Read moreCompany Overview: Gartner, Inc. (NYSE: IT) is a global research and advisory firm providing insights and consulting in information technology and related fields. The company…
By Franklin Jay
Read moreInsight Molecular Diagnostics (NASDAQ: IMDX) – formerly Oncocyte Corp (NASDAQ: OCX) – is a small-cap molecular diagnostics company on the cusp of a pivotal milestone. The company…
By Franklin Jay
Read moreCompany Overview & 2025 Highlights Zentalis Pharmaceuticals (NASDAQ: ZNTL) is a clinical-stage biotech focused on developing azenosertib (ZN-c3), a novel WEE1 kinase inhibitor,…
By Franklin Jay
Read moreAnavex Life Sciences Corp. (NASDAQ: AVXL) is a clinical-stage biopharmaceutical company focused on central nervous system (CNS) disorders, with a lead drug candidate blarcamesine…
By Franklin Jay
Read moreOverview and Recent Developments Circle Internet Group (NYSE: CRCL) is the U.S.-based issuer of USD Coin (USDC), the world’s second-largest U.S. dollar stablecoin. Circle went…
By Franklin Jay
Read moreQuantum BioPharma Ltd. (QNTM) – formerly FSD Pharma – is a Canadian biopharmaceutical company focused on innovative treatments for neurodegenerative, inflammatory, and metabolic…
By Franklin Jay
Read moreCompany Overview and Recent Developments Integer Holdings Corporation (NYSE: ITGR) is a leading medical device contract development and manufacturing company, serving OEMs in…
By Franklin Jay
Read moreEli Lilly & Co. (NYSE: LLY) shares have surged on news of a successful Phase 3 trial – dubbed “ADorable-1” – delivering positive results in a critical therapeutic area. Investors…
By Franklin Jay
Read moreClass Action Lawsuit – What Happened? A securities class action lawsuit has been filed on behalf of Mereo BioPharma (NASDAQ: MREO) investors who bought the stock between June 5,…
By Franklin Jay
Read moreCompany Overview: uniQure N.V. (NASDAQ: QURE) is a Dutch biopharma specializing in gene therapies (en.wikipedia.org). It developed Hemgenix (etranacogene dezaparvovec) for…
By Franklin Jay
Read morePipeline Highlights at AD/PD Conference ProMIS Neurosciences (NASDAQ: PMN) recently showcased new data from its amyotrophic lateral sclerosis (ALS) and Parkinson’s disease…
By Franklin Jay
Read moreTicker: KGEI (Kolibri Global Energy Inc.) – NASDAQ listing; also TSX: KEI Meet the 3 Pillars of Dollar 2.0 Tap to flip the card for names, tickers, and a quick playbook.…
By Franklin Jay
Read moreCompany Overview and FY2025 Highlights Annovis Bio (NYSE: ANVS) is a clinical-stage biotech focused on developing therapies for neurodegenerative diseases, particularly…
By Franklin Jay
Read moreMicrosoft (MSFT) is one of the world’s largest companies and a pillar of the technology sector (www.kiplinger.com). Its business spans a legacy productivity software empire…
By Franklin Jay
Read moreIntroduction Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company whose stock has recently come under intense scrutiny following the collapse…
By Franklin Jay
Read moreCompany Overview & Recent Developments Mereo BioPharma Group plc (NASDAQ: MREO) is a UK-based clinical-stage biopharmaceutical company focused on developing therapies for rare…
By Franklin Jay
Read moreIntroduction Cybin Inc. – now operating as Helus Pharma (Nasdaq: HELP) – is a clinical-stage biopharmaceutical company focused on innovative psychedelic-based therapeutics for…
By Franklin Jay
Read moreIntroduction Urgent Class Action Deadline: VistaGen Therapeutics (NASDAQ: VTGN) shareholders face a March 16, 2026 deadline to seek lead-plaintiff status in a securities class…
By Franklin Jay
Read more
